Skip to main content
. 2007 May 8;96(11):1625–1632. doi: 10.1038/sj.bjc.6603771

Table 1. Quality rating of included studies.

  Grunfeld (1996) Gulliford et al (1997) Brown et al (2002) Koinberg et al (2004) Baildam et al (2004) Kokko et al (2005) Grunfeld et al (2006)
Is the population under study defined (with inclusion and exclusion criteria)? Yes Yes No (exclusion criteria omitted) Yes No Yes Yes
Are the main prognostic factors defined (at least age of patient and stage of tumour)? Yes Yes Yes Yes No Yes Yes
Is treatment of first tumour specified? Yes Yes Yes Yes No Yes Yes
Has a power calculation been carried out to assess the required cohort size? Yes No No Yes No No Yes
Is cohort size sufficient for primary outcome measure (i.e. greater than any calculated sample size or of sufficient size to detect clinically significant difference)? Yes Yes No Yes Yes Yes No
Is a comparison made of baseline characteristics (age and stage) between participants and those who refuse to participate? Yes Yes Yes No No No No
Is mean or median follow up greater than 5 years? No No No Yes Not given No No
Is loss during follow up specified? Yes No Yes No No No No
Is the follow up schedule (including mammographic interval) specified? Yes Yes No Yes No Yes Yes
Is mammographic frequency identical between follow-up groups? Yes Yes Yes Yes Not given Yes Yes
Are mostly objective or validated outcomes used? Yes No Yes Yes Yes Yes Yes
Were outcomes prospectively assessed? Yes Yes Yes Yes Yes Yes Yes
Was the article published in peer reviewed journal? Yes Yes Yes Yes No Yes Yes
Total score 12 9 8 11 3 9 9